Proprietary safety intelligence creates dual value: faster therapeutic development and biodefense. LOS ANGELES, CALIFORNIA / ...

Unlike traditional approaches that typically test one protein target or drug at a time in hopes of identifying an effective ...

Discovering new medicines takes years and is marred by an astronomical failure rate. The Nobel Prize-winning head of Alphabet ...

A new AI Drug Discovery tool called PDGrapher can predict more accurate drug combinations up to 25 times faster than previous ...

AI in drug discovery has carried promise and a nagging problem: models that predict without explaining. Vian Analytics steps ...

Absci (ABSI) stock in focus as the company teams up with Oracle (ORCL) and AMD (AMD) to boost AI-powered drug discovery. Read ...

Enveda Biosciences has raised $300 million over the last year to make drugs to treat atopic dermatitis, asthma and more.

Advanced Micro Devices (AMD) experienced a notable increase of 35% over the last quarter, amidst its key collaboration with ...

Advanced Micro Devices (AMD) recently formed a collaboration with Oracle Cloud Infrastructure and Absci to advance AI-driven drug discovery, leveraging its cutting-edge hardware like the Instinct ...

Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results ...

Using reprogrammed biocatalysts, researchers are pushing the boundaries of enzymatic synthesis with a method that opens the ...

Demis Hassabis, the head of Google's DeepMind, believes AI will soon revolutionise medicine, accelerating the drug discovery ...